替吉奥胶囊单药三线治疗老年晚期结直肠癌的疗效分析

中国药物警戒 ›› 2016, Vol. 13 ›› Issue (5): 263-265.

替吉奥胶囊单药三线治疗老年晚期结直肠癌的疗效分析

吕建华,吕建莉,李永兵,

濮阳市人民医院，河南濮阳 457000

收稿日期:2015-06-02 修回日期:2016-06-30 出版日期:2016-05-20 发布日期:2016-06-30
作者简介:吕建华，女，本科，主管药师，医院药学。

Analysis of Efficacy of S-1 Capsale Monotherapy Third-line Treatment in Elderly Patients with Advanced Colorectal Cancer

LV Jian-hua, LV Jian-li, LI Yong-bing

Puyang People'
s Hospital, Henan Puyang 457000, China

Received:2015-06-02 Revised:2016-06-30 Online:2016-05-20 Published:2016-06-30

摘要/Abstract

摘要： 目的探讨替吉奥胶囊单药三线治疗老年晚期结直肠癌的临床疗效。方法选取我院2013年8月至2014年8月收治的老年晚期结直肠癌患者66例，采用随机数字法将其分为观察组与对照组，每组33例，观察组患者应用三线替吉奥胶囊单药治疗，对照组患者应用卡培他滨片治疗，观察对比两组患者使用药物疗效及不良反应。结果观察组患者的临床有效率为45.45%，对照组为42.42%，两组患者对比无显著差异（P＞0.05）；观察组患者KPS评分改善明显高于对照组，两组对比差异显著（P＜0.05）；观察组患者腹泻及手足综合证的发生率明显低于对照组，两组患者对比差异显著（P＜0.05）。结论老年晚期结直肠癌患者应用替吉奥胶囊单药三线治疗临床疗效确切，不良反应较小，给药方便，可提高患者生活质量，同时患者耐受能力较高，值得临床治疗进一步应用及推广。

关键词: 晚期结直肠癌, 老年患者, 替吉奥胶囊

Abstract: Objective To investigate the clinical efficacy of S^-1 monotherapy third-line treatment in elderly patients with advanced colorectal cancer. Methods 66 cases of senile advanced colorectal cancer patients were selected in our hospital from August 2013 to August 2014, who were randomly divided into the observation group and the control group with 33 cases in each group. In observation group, third-line S^-1 monotherapy was applicated, while the patients in control group were treated with capecitabine tablets. The efficacy and side effects of the drugs were observed and compared between the two groups of patients. Results In the observation group patients, the clinical effective rate was 45.45%, while it was 42.42% in the control group. There was no significant difference (P > 0.05) between the two groups of patients. Improvement of KPS score in the observation group was significantly higher than that of the control group with significant difference between the two groups (P < 0.05).Diarrhea and hand foot syndrom incidence in observation group was significantly lower than that of the control group, which was significantly different (P < 0.05). Conclusion In elderly patients with advanced colorectal cancer, S^-1 capsule monotherapy third-line treatment is effective with less adverse reactions and dosing convenience. It can improve the life quality of patients, also with a higher tolerance. It is worthy to be further applicated and promoted in clinic.

Key words: advanced colorectal cancer, elderly patient, S-1 capsule

中图分类号:

R994.11

吕建华,吕建莉,李永兵,. 替吉奥胶囊单药三线治疗老年晚期结直肠癌的疗效分析[J]. 中国药物警戒, 2016, 13(5): 263-265.

LV Jian-hua, LV Jian-li, LI Yong-bing . Analysis of Efficacy of S-1 Capsale Monotherapy Third-line Treatment in Elderly Patients with Advanced Colorectal Cancer[J]. Chinese Journal of Pharmacovigilance, 2016, 13(5): 263-265.

参考文献

[1] 张丽,白学章,庞娟，等.替吉奥单药治疗老年晚期结直肠癌近期疗效观察[J].中国医药指南, 2011, 9(24):289-290.
[2] 刘俊才,朱红静.替吉奥治疗老年结直肠癌疗效观察[J].中国现代药物应用, 2012, 6(20):51-52.
[3] 陈晓梅.两种药物联合治疗老年晚期结直肠癌的临床研究[J].检验医学与临床, 2013, 10(4):392-393,395.
[4] 杨华,肖刚,汪欣,等.老年结直肠癌根治性切除患者的预后分析[J].中华老年医学杂志, 2015, 34(4):400-404.
[5] 张西.替吉奥在中晚期胃癌治疗中的研究进展[J].中国老年保健医学, 2011, 9(5):56-57.
[6] 李俊,丁纪元,郑婉珍,等.雷替曲塞联合腹部热疗治疗老年结直肠癌的临床观察[J].中国慢性病预防与控制, 2013, 21(5):615-617.
[7] Diaz Gonzalez J A, Calvo F A, Cortes J, et al.Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer.[J].International Journal of Radiation Oncology, Biology, Physics, 2005, 61(5):1378-1384.
[8] 王毅，宋世铎，张忠军.老年结直肠癌发病及外科手术特点[J].实用临床医药杂志，2010, 14（21）:112.
[9] 江艺，邱希辉，陈志明，等. 5-氟尿嘧啶为主方案治疗晚期贲门癌及预后因素分析[J].中华肿瘤防治杂志, 2007, 14(16):1257.
[10] LeeD J, Lee H Y, LeeG Y, et al. Salvages-1 to onotherapv intn
etastatic colorectal cancer patients who failed irinotecan一based or oxalipatin-based chetmotherapy[J]. Med oncol, 2011, 28(s1):S291-S294.
[11] 秦叔逾，马军.中国临床肿瘤学进展[M].北京:人民卫生出版社，2011:251-258.
[12] Blum M, Snznki A, A jan J A. A compreliensive revview of S-1 in the treatment of advanced gastric adenoarcinoma[J]. Fnhue Oncol, 2011, 7( 6):715.
[13] 吕杰.老年患者腹腔镜结直肠癌手术的临床分析[J].中外医疗,2013, 32(15):5,7.
[14] 王吉.西妥昔单抗联合替吉奥治疗老年转移性结直肠癌的临床观察[J].中国医药, 2012, 7(7):873-875.
[15] 张彤,马晓,张蕊,等.替吉奥治疗老年或功能状态评分差晚期结直肠癌患者的疗效观察[J].中国全科医学, 2013, 16(3):305-307.